Blood clot risk in inflammatory bowel disease
Part of Digestive system clinical trials.
This study looks at whether people with inflammatory bowel disease (IBD) have a higher chance of blood clots due to inherited factors. It compares clotting risks during active disease and when the disease is quiet, which could help guide prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must not be pregnant.
- You must not have had surgery recently.
- You must not have a history of cancer.
- You must not have had a blood transfusion in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how fats in your blood and gut lining change in inflammatory bowel disease (IBD). It might help doctors understand IBD better and could lead to better treatments.
This study looks at whether certain blood tests (called inflammatory biomarkers) can help measure how active your inflammatory bowel disease (Crohn's disease or ulcerative colitis) is. It may help doctors better track your condition and guide treatment, without needing invasive procedures.
This study looks at the size and activity of platelets (the cells that help blood clot) in patients with ulcerative colitis or Crohn's disease, to see if they can be used as markers of inflammation. It is a simple blood test study that may help better understand your condition.
This study looks at how anemia (low red blood cells) affects the course of inflammatory bowel disease (IBD) in adults. It may help doctors understand if anemia can predict how the disease progresses, which could guide better treatment.
This study looks at whether a leaky gut in people with inflammatory bowel disease (IBD) is linked to a higher risk of blood clots and blood vessel damage. It aims to find new ways to prevent these complications.
This study watches people who might be more likely to get Inflammatory Bowel Disease (IBD). It looks at close family members of IBD patients, people with autoimmune diseases, and those with certain digestive issues who also have a specific blood marker (ASCA). The goal is to find early signs and possibly prevent the disease.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.